KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.
about
The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients.KRAS mutation in lung metastases from colorectal cancer: prognostic implications.Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.KRAS exon 2 codon 13 mutation is associated with a better prognosis than codon 12 mutation following lung metastasectomy in colorectal cancer.The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors.RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomy.Perioperative bevacizumab improves survival following lung metastasectomy for colorectal cancer in patients harbouring v-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue exon 2 codon 12 mutations†.Specific KRAS amino acid substitutions and EGFR mutations predict site-specific recurrence and metastasis following non-small-cell lung cancer surgery.Clinical impact of c-MET expression and mutational status in patients with colorectal cancer lung metastases.Lung metastasectomy: an experience-based therapeutic option.Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.MicroRNAs: a new tool in the complex biology of KRAS mutated non-small cell lung cancer?Molecular profiling of colorectal pulmonary metastases and primary tumours: implications for targeted treatmentComment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy.Reply: Comment on 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colo-rectal cancer'.Classification of gene signatures for their information value and functional redundancy.Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers.BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives.KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study.How can we identify new biomarkers for patients with for lung metastasectomy in colorectal cancer.Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
P2860
Q33768220-11E81E60-3B8D-453C-AAB5-2B57F37A5161Q36528345-183283BB-60D2-4502-B876-13AB65B2D4FFQ37525272-54821F22-DA7E-4960-BF62-59C2AA36BFF7Q37709323-D9F4DE38-AD5D-4F61-97FB-EC5DDBEDF3F9Q38481038-F9AF0FA5-1BE3-45BB-AABF-A2446194B53EQ38785379-3757DDD3-9512-4764-A964-2A4895EE10EAQ38967826-F33485DA-26D1-431A-A73D-27AA629FC3A2Q39660590-68E27BAA-B5D4-41D9-90DD-8C8370A879D3Q40390326-31C768B9-6577-43FE-A3C0-9841002754D7Q42042729-97CC1F27-1AFC-4933-9C3B-F62299E9BBD2Q42276714-0AD164FE-AFE7-4114-838C-A39F799E2875Q42354892-AAB6D2B3-2EED-466B-98BE-D8C74C9E5CF4Q42371494-FF36F760-0B35-40FC-BD84-6A6ABFCE920EQ43099377-563829C9-3746-40AA-9BB5-42279A6422C7Q43099383-76A5B0B3-5E55-4C30-9E8E-32C6BB5C13F2Q47102166-43DBA97F-8BEA-48A6-9BEF-57C6724A8470Q47376223-1BDD07D2-BDBE-47F3-9BE4-F95F1572A9D4Q47767987-F97CF723-C978-4E1A-AB34-C6A60EE54127Q48097655-A146B6E6-1401-416A-BD1C-C38F7558B3ACQ48420601-6AB1A1E8-25AA-46A7-9848-9C0D8A98DA03Q50086554-2996AEEF-F294-49F6-8084-CAF2B67626BE
P2860
KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
KRAS and BRAF mutations are pr ...... asectomy of colorectal cancer.
@ast
KRAS and BRAF mutations are pr ...... asectomy of colorectal cancer.
@en
type
label
KRAS and BRAF mutations are pr ...... asectomy of colorectal cancer.
@ast
KRAS and BRAF mutations are pr ...... asectomy of colorectal cancer.
@en
prefLabel
KRAS and BRAF mutations are pr ...... asectomy of colorectal cancer.
@ast
KRAS and BRAF mutations are pr ...... asectomy of colorectal cancer.
@en
P2093
P2860
P356
P1476
KRAS and BRAF mutations are pr ...... asectomy of colorectal cancer.
@en
P2093
N Santelmo
P-E Falcoz
P2860
P2888
P304
P356
10.1038/BJC.2014.499
P407
P577
2015-02-01T00:00:00Z
P6179
1007958273